The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update (Q38208428)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 April 2014

Language	Label	Description	Also known as
English	The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update	scientific article published on 30 April 2014

Statements

scholarly article

1 reference

Europe PubMed Central

31 August 2017

The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update (English)

1 reference

Europe PubMed Central

31 August 2017

0 references

1 reference

based on heuristic

inferred from title

Torsten Zuberbier

1

object named as

T Zuberbier

1 reference

Europe PubMed Central

31 August 2017

Giorgio Walter Canonica

6

object named as

G W Canonica

1 reference

Europe PubMed Central

31 August 2017

object named as

B Wedi

29

0 references

Margarida Gonçalo

object named as

M Gonçalo

11

0 references

Carsten Bindslev-Jensen

object named as

C Bindslev-Jensen

4

0 references

27

object named as

E Toubi

1 reference

Europe PubMed Central

31 August 2017

31

object named as

M Maurer

1 reference

Europe PubMed Central

31 August 2017

European Dermatology Forum

34

object named as

European Dermatology Forum

1 reference

Europe PubMed Central

31 August 2017

5

object named as

Z Brzoza

1 reference

Europe PubMed Central

31 August 2017

P. Mathelier-Fusade

18

object named as

P Mathelier-Fusade

1 reference

Europe PubMed Central

31 August 2017

Mario Sanchez-Borges

22

object named as

M Sánchez-Borges

1 reference

Europe PubMed Central

31 August 2017

World Allergy Organization

35

object named as

World Allergy Organization

1 reference

Europe PubMed Central

31 August 2017

Global Allergy and Asthma European Network

33

object named as

Global Allergy and Asthma European Network

1 reference

Europe PubMed Central

31 August 2017

F. Estelle R. Simons

24

object named as

F E R Simons

1 reference

Europe PubMed Central

31 August 2017

author name string

W Aberer

2

1 reference

Europe PubMed Central

31 August 2017

R Asero

3

1 reference

Europe PubMed Central

31 August 2017

M K Church

7

1 reference

Europe PubMed Central

31 August 2017

L F Ensina

8

1 reference

Europe PubMed Central

31 August 2017

A Giménez-Arnau

9

1 reference

Europe PubMed Central

31 August 2017

K Godse

10

1 reference

Europe PubMed Central

31 August 2017

C Grattan

12

1 reference

Europe PubMed Central

31 August 2017

J Hebert

13

1 reference

Europe PubMed Central

31 August 2017

M Hide

14

1 reference

Europe PubMed Central

31 August 2017

A Kaplan

15

1 reference

Europe PubMed Central

31 August 2017

A Kapp

16

1 reference

Europe PubMed Central

31 August 2017

A H Abdul Latiff

17

1 reference

Europe PubMed Central

31 August 2017

M Metz

19

1 reference

Europe PubMed Central

31 August 2017

A Nast

20

1 reference

Europe PubMed Central

31 August 2017

S S Saini

21

1 reference

Europe PubMed Central

31 August 2017

P Schmid-Grendelmeier

23

1 reference

Europe PubMed Central

31 August 2017

P Staubach

25

1 reference

Europe PubMed Central

31 August 2017

G Sussman

26

1 reference

Europe PubMed Central

31 August 2017

G A Vena

28

1 reference

Europe PubMed Central

31 August 2017

X J Zhu

30

1 reference

Europe PubMed Central

31 August 2017

European Academy of Allergy and Clinical Immunology

32

1 reference

Europe PubMed Central

31 August 2017

publication date

30 April 2014

1 reference

Europe PubMed Central

31 August 2017

1 reference

Europe PubMed Central

31 August 2017

69

1 reference

Europe PubMed Central

31 August 2017

868-887

1 reference

Europe PubMed Central

31 August 2017

7

1 reference

Europe PubMed Central

31 August 2017

EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Definition, classification, and routine diagnosis of urticaria: a consensus report

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Management of urticaria: a consensus report

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

EAACI/GA2LEN/EDF guideline: management of urticaria.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Going from evidence to recommendations

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

What is "quality of evidence" and why is it important to clinicians?

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Basophil recruitment and activation in inflammatory skin diseases.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Clinical practice. Chronic urticaria and angioedema

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

The extent and nature of disability in different urticarial conditions

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL).

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Cross-cultural adaptation of the Brazilian-Portuguese version of the chronic urticaria quality-of-life questionnaire - CU-Q2oL.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Turkish version of the chronic urticaria quality of life questionnaire: cultural adaptation, assessment of reliability and validity

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

How to assess disease activity in patients with chronic urticaria?

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Anisakis simplex hypersensitivity is associated with chronic urticaria in endemic areas

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Anisakis simplex: sensitization and clinical allergy

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Pseudoallergic reactions in chronic urticaria are associated with altered gastroduodenal permeability

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Chronic urticaria and infections

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Prevalence of Helicobacter pylori-associated gastritis in chronic urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Helicobacter pylori infection in skin diseases: a critical appraisal

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

IgE mediated autoallergy against thyroid peroxidase--a novel pathomechanism of chronic spontaneous urticaria?

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

The definition and diagnostic testing of physical and cholinergic urticarias--EAACI/GA2LEN/EDF/UNEV consensus panel recommendations

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Chronic urticaria: novel clinical and serological aspects

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Autoreactivity is highly prevalent in patients with multiple intolerances to NSAIDs

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Evidence for aberrant regulation of the p21Ras pathway in PBMCs of patients with chronic idiopathic urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Frequency and clinical implications of skin autoreactivity to serum versus plasma in patients with chronic urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Autologous serum skin test for autoantibodies is associated with airway hyperresponsiveness in patients with asthma.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Novel clinical and serological aspects in non-allergic asthma.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Autologous serum skin test reactivity in patients with non-allergic asthma

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Sera from patients with multiple drug allergy syndrome contain circulating histamine-releasing factors

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Allergy-like asthma and rhinitis. A cross-sectional survey of a respiratory cohort and a diagnostic approach using the autologous serum skin test.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Heparin and tranexamic Acid therapy may be effective in treatment-resistant chronic urticaria with elevated d-dimer: a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Peltier effect-based temperature challenge: an improved method for diagnosing cold urticaria.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

A novel, simple, validated and reproducible instrument for assessing provocation threshold levels in patients with symptomatic dermographism.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

An update on childhood urticaria and angioedema

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Role of nonallergic hypersensitivity reactions in children with chronic urticaria.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Chronic urticaria in childhood

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Unmet needs in severe chronic upper airway disease (SCUAD).

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Drug-induced urticarias

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Effectiveness of Helicobacter pylori eradication in chronic urticaria: evidence-based analysis using the Grading of Recommendations Assessment, Development, and Evaluation system

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Urticaria and infections

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Etiologic aspects of chronic urticaria.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Lack of correlation between Helicobacter pylori infection and autologous serum skin test in chronic idiopathic urticaria.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Urticaria and angio-oedema. A review of 554 patients

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Plasmapheresis for severe, unremitting, chronic urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Incremental build-up food challenge--a new diagnostic approach to evaluate pseudoallergic reactions in chronic urticaria: a pilot study: stepwise food challenge in chronic urticaria.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Sodium benzoate-induced repeated episodes of acute urticaria/angio-oedema: randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Can on-demand non-sedating antihistamines improve urticaria symptoms? A double-blind, randomized, single-dose study.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

New concepts in chronic urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Double-blind crossover study of high-dose cetirizine in cholinergic urticaria.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

In vivo studies of mediator release in cold urticaria and cholinergic urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Effect of omalizumab on patients with chronic urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Treatment of chronic spontaneous urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Omalizumab in chronic urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Omalizumab for chronic urticaria: a case series and overview of the literature

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: a real life survey.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Omalizumab in treatment-resistant chronic spontaneous urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Successful treatment of solar urticaria with anti-immunoglobulin E therapy

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Effective treatment of refractory severe heat urticaria with omalizumab

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Efficacy of omalizumab in delayed pressure urticaria: a case report

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Anti-Immunoglobulin E Treatment of Patients with Recalcitrant Physical Urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Role of calcineurin in the regulation of human lung mast cell and basophil function by cyclosporine and FK506.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Experience with cyclosporine in children with chronic idiopathic urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Indolent systemic mastocytosis treated with narrow-band UVB phototherapy: study of five cases.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Narrowband ultraviolet B phototherapy is beneficial in antihistamine-resistant symptomatic dermographism: a pilot study.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Delayed pressure urticaria, objective evaluation of a variable disease using a dermographometer and assessment of treatment using colchicine

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

The safety of cetirizine during pregnancy. A prospective observational cohort study

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Risk of hypospadias in offspring of women using loratadine during pregnancy: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FALL.12313

21 January 2018

Identifiers

10.1111/ALL.12313

1 reference

Europe PubMed Central

31 August 2017

1 reference

Europe PubMed Central

31 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38208428&oldid=2140898126"